Fibrocell Science, Inc. (11)
Browse by Contract Category
Contracts
-
Side Letter Agreement, dated September 12, 2019 by and between Castle Creek Pharmaceutical Holdings, Inc., Castle Creek Pharmaceuticals, LLC and Fibrocell Science, Inc
(Filed With SEC on November 14, 2019)
-
Consent and Termination Agreement, dated as of September 12, 2019, among Fibrocell Science, Inc., Castle Creek Pharmaceutical Holdings, Inc., Castle Creek Merger Corp. and MSD...
(Filed With SEC on September 13, 2019)
-
Consent and Termination Agreement, dated as of September 12, 2019, among Fibrocell Science, Inc. and the other signatories thereto
(Filed With SEC on September 13, 2019)
-
Amended and Restated Employment Agreement, dated August 20, 2019, by and between Fibrocell Science, Inc. and John M. Maslowski
(Filed With SEC on August 22, 2019)
-
Co-Development and License Agreement, dated April 12, 2019, by and between Castle Creek Pharmaceuticals, LLC and Fibrocell Science, Inc
(Filed With SEC on August 14, 2019)
-
Agreement and Plan of Merger, dated as of September 12, 2019, among Fibrocell Science, Inc., Castle Creek Pharmaceutical Holdings, Inc., and Castle Creek Merger Corp
(Filed With SEC on September 13, 2019)
-
Employment Agreement, dated August 20, 2019, by and between Fibrocell Science, Inc. and Sean D. Buckley
(Filed With SEC on August 22, 2019)
-
Fibrocell Science, Inc. 2019 Equity Incentive Plan
(Filed With SEC on June 14, 2019)
-
Form of Award Agreement - ISO Grant Employee
(Filed With SEC on June 14, 2019)
-
Form of Award Agreement - NQ Grant Employee
(Filed With SEC on June 14, 2019)
-
Form of Award Agreement - NQ Grant Director
(Filed With SEC on June 14, 2019)